论文部分内容阅读
1971年Russell等报道癌症患者尿中多胺排量增多。此后,许多作者作了类似报道并认为测定尿多胺可作为诊断和判断肿瘤治疗效果的化学指示。目前高效液相色谱(HPLC)仪已逐渐普及,国内曾报道用国产填料对多胺标准品得到满意分离结果。我们应用此法测定癌症患者的尿多胺有明显增多,可为临床诊断癌症和疗效观察提供一种工具。
In 1971, Russell et al. Reported that there was an increase in urinary polyamines in cancer patients. Since then, many authors have similarly reported that the determination of urinary polyamines can be used as a chemical indicator to diagnose and determine the effects of oncology treatments. At present, high performance liquid chromatography (HPLC) instrument has been gradually popularized, it has been reported in China using domestic fillers polyamine standards were satisfactory results. We use this method for the determination of cancer patients with significantly increased urinary polyamines, for the clinical diagnosis of cancer and provide a tool for observation.